Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Bafna Pharmaceuticals Revenue

Bafna Pharmaceuticals had revenue of 265.83M INR in the quarter ending June 30, 2026, a decrease of -23.22%. This brings the company's total for the last twelve months to 1.43B, down -3.14% year-over-year. In the fiscal year ending March 31, 2026, Bafna Pharmaceuticals had annual revenue of 1.51B with 3.26% growth. That makes Bafna Pharmaceuticals the 35,375th largest company in the world by revenue and 2,892nd in India.

• Revenue (ttm): 1.43B
• Revenue Growth: -3.14%
• P/S Ratio: 7.54
• Revenue / Employee: 4.21M
• Employees: 339
• Market Cap: 10.75B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Export 958.11M 63.6%
• India 519.77M 34.5%
• Unallocated 28.30M 1.9%

Fiscal year ended Mar 31, 2026 See the full Bafna Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.51B	47.60M	3.26%
Mar 31, 2025	1.46B	-66.09M	-4.33%
Mar 31, 2024	1.52B	371.16M	32.18%
Mar 31, 2023	1.15B	302.10M	35.48%
Mar 31, 2022	851.40M	139.22M	19.55%

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error